Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab + lenvatinib versus docetaxel for metastatic NSCLC after platinum doublet chemotherapy and immunotherapy
Phase: 3Phase III in Spain, 2Phase II, 1Phase I